寒冷療法市場：製品、用途、治療タイプ、流通チャネル、地域別、2024年～2031年

寒冷療法市場の評価、2024年～2031年

非侵襲的疼痛管理ソリューションの利点に対する認識の高まりが市場規模を拡大Verified Market Researchのアナリストによると、寒冷療法市場は、2024年には約10億7,192万米ドルの評価額を超え、予測期間中に15億5,262万米ドルの評価額に達すると推定されています。

寒冷療法市場の急拡大は、主に慢性疼痛状態の有病率の上昇に起因しており、効果的な疼痛緩和オプションに対する需要の高まりにつながっています。このため、2024年から2031年にかけて、同市場はCAGR4.74％で成長する見込みです。

寒冷療法市場定義/概要

寒冷療法は、冷温を利用して痛みを緩和し、炎症を抑える治療法です。氷嚢、ジェルパック、凍結療法機器など様々な治療法が採用され、急性外傷、術後の回復、慢性疼痛状態に対して標的を絞った疼痛緩和を行う。痛みを麻痺させ、腫れを最小限に抑える寒冷療法の有効性は、整形外科、スポーツ医学、物理的リハビリテーションを含む複数の医療分野で認められています。

非侵襲的で薬剤を使用しない疼痛管理ソリューションに対する需要が高まっている背景には、寒冷療法に関連する利点に対する認識が高まっていることがあります。スポーツ関連の怪我や筋骨格系障害の発生率の上昇、慢性疼痛状態に陥りやすい高齢化などの要因が、市場の拡大に寄与しています。ヘルスケア専門家が冷温療法を効果的な治療法として支持し続けていることから、冷温疼痛療法市場は今後数年間で大きな成長が見込まれます。

慢性疼痛疾患の有病率の増加は、寒冷療法市場にどのような影響を与えていますか？

慢性疼痛疾患の有病率の増加は、効果的な疼痛管理ソリューションに対する需要を増加させることで、寒冷療法市場に大きな影響を与えています。米国疾病予防管理センター（CDC）によると、2019年には米国成人の推定20.4％（5,020万人）が慢性疼痛を有し、成人の7.4％（1,960万人）が生活や仕事の活動を頻繁に制限するような影響の大きい慢性疼痛を有していました。人口の高齢化や生活習慣の問題など、さまざまな要因が慢性疼痛患者の増加に寄与しています。その結果、非侵襲的で薬物を使用しない治療法の必要性がヘルスケアプロバイダーによって強調され、冷温療法の採用が増加しました。

患者が薬物療法に代わる治療法を求める中、寒冷療法の治療効果が広く認識されるようになっています。市場の成長をさらに後押ししているのは、痛みや炎症を抑える冷温療法の有効性を強調する継続的な調査です。認知度が高まるにつれて、寒冷療法の採用は拡大し、市場全体の拡大を牽引すると予想されます。

寒冷療法機器の技術進歩は市場成長にどのような影響を与えていますか？

寒冷療法機器の技術的進歩は、寒冷痛覚療法の効果とユーザー体験を向上させることで、市場成長に影響を与えています。ポータブル凍結治療器や温度調節可能なスマートアイスパックなどの技術革新が開発され、より的を絞った効率的な疼痛管理が可能になりました。タイマーやモバイルアプリケーションなどの機能が統合されたことで、これらの機器はより利用しやすく、ユーザーフレンドリーになっています。

さらに、こうした先進的な機器の有効性を裏付ける臨床研究が、医療現場での信頼性を高めています。ヘルスケアプロバイダーがこれらの革新的技術について知識を深めるにつれて、疼痛管理への使用を推奨する頻度も高まっています。この動向は、技術的に先進的な寒冷療法ソリューションの市場シェア拡大につながっており、患者にもヘルスケア専門家にも好まれる選択肢となっています。

目次

第1章 世界の寒冷療法市場：イントロダクション

• 市場概要
• 調査範囲
• 前提条件

第2章 エグゼクティブサマリー

第3章 VERIFIED MARKET RESEARCHの調査手法

• データマイニング
• バリデーション
• 一次資料
• データソース一覧

第4章 寒冷療法の世界市場展望

• 概要
• 市場力学
  • 促進要因
  • 抑制要因
  • 機会
• ポーターのファイブフォースモデル
• バリューチェーン分析

第5章 寒冷療法の世界市場：製品別

• 概要
• OTC製品
  • クリーム
  • ジェル
  • パッチ
  • その他
• 処方薬
  • 医薬品
  • 医療機器

第6章 寒冷療法の世界市場：用途別

• 概要
• 筋骨格系疾患
• 術後療法
• 外傷後療法
• スポーツ医学

第7章 寒冷療法の世界市場：地域別

• 概要
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • その他欧州
• アジア太平洋
  • 中国
  • 日本
  • インド
  • その他アジア太平洋地域
• 世界のその他の地域
  • ラテンアメリカ
  • 中東・アフリカ

第8章 世界の寒冷療法市場の競合情勢

• 概要
• 各社の市場ランキング
• 主な発展戦略

第9章 企業プロファイル

• Breg, Inc
• Beiersdorf AG
• A-ssur HF
• 3M Company
• DJO Finance LLC
• Hisamitsu Pharmaceutical Co., Inc
• Johnson & Johnson
• Medline Industries, Inc
• Rohto Pharmaceutical Co., Ltd
• Sanofi

第10章 付録

• 関連調査

Cold Pain Therapy Market Valuation - 2024-2031

Increasing awareness of the benefits of non-invasive pain management solutions is driving the market size of the market. According to the analyst from Verified Market Research, the Cold Pain Therapy Market is estimated to reach a valuation of USD 1552.62 Million over the forecast subjugating around USD 1071.92 Million valued in 2024.

The rapid expansion of the cold pain therapy market is primarily driven by the rising prevalence of chronic pain conditions, which is leading to increased demand for effective pain relief options. It enables the market to grow at aCAGR of 4.74% from 2024 to 2031.

Cold Pain Therapy Market: Definition/ Overview

Cold pain therapy is a treatment method that utilizes cold temperatures to alleviate pain and reduce inflammation. Various modalities, including ice packs, gel packs, and cryotherapy devices, are employed in this therapy to provide targeted pain relief for acute injuries, postoperative recovery, and chronic pain conditions. The effectiveness of cold therapy in numbing pain and minimizing swelling has been recognized across multiple medical disciplines, including orthopedics, sports medicine, and physical rehabilitation.

Increasing demand for non-invasive and drug-free pain management solutions is being driven by a growing awareness of the benefits associated with cold pain therapy. Factors such as the rising incidence of sports-related injuries and musculoskeletal disorders, along with an aging population prone to chronic pain conditions, are contributing to the market's expansion. As healthcare professionals continue to endorse cold therapy as an effective treatment option, the market for cold pain therapy is anticipated to experience significant growth in the coming years.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

What Impact is the Rising Prevalence of Chronic Pain Conditions having on the Cold Pain Therapy Market?

The rising prevalence of chronic pain conditions is significantly impacting the cold pain therapy market by increasing the demand for effective pain management solutions. According to the Centers for Disease Control and Prevention (CDC), in 2019, an estimated 20.4% of U.S. adults (50.2 million) had chronic pain, and 7.4% of adults (19.6 million) had high-impact chronic pain that frequently limited life or work activities. Various factors, including the aging population and lifestyle-related issues, have contributed to the escalation of chronic pain cases. Consequently, the need for non-invasive and drug-free treatment options has been emphasized by healthcare providers, leading to an uptick in the adoption of cold therapy modalities.

As patients seek alternatives to pharmacological treatments, the therapeutic benefits of cold pain therapy are being recognized more widely. Market growth is further supported by ongoing research that highlights the efficacy of cold therapy in reducing pain and inflammation. As awareness increases, the adoption of cold pain therapy is anticipated to grow, thereby driving the overall market expansion.

How are Technological Advancements in Cold Therapy Devices Influencing the Market Growth?

Technological advancements in cold therapy devices are influencing market growth by enhancing the effectiveness and user experience of cold pain therapy. Innovations, such as portable cryotherapy machines and smart ice packs with adjustable temperature controls, have been developed, allowing for more targeted and efficient pain management. The integration of features such as timers and mobile applications has made these devices more accessible and user-friendly.

Furthermore, clinical studies supporting the efficacy of these advanced devices have bolstered their credibility in medical settings. As healthcare providers become more informed about these innovations, recommendations for their use in pain management are being made more frequently. This trend is leading to an increased market share for technologically advanced cold pain therapy solutions, thereby positioning them as preferred choices among patients and healthcare professionals alike.

Category-Wise Acumens

What Factors are Contributing to the Dominance of OTC-Based Products in the Cold Pain Therapy Market?

According to VMR Analyst, the dominance of OTC-based products in the Cold Pain Therapy market is being driven by several key factors. Increasing consumer preference for self-management of pain has resulted in a higher demand for over-the-counter solutions, which are perceived as convenient and accessible. As awareness regarding the benefits of cold therapy for pain relief grows, more individuals are opting for OTC options rather than seeking prescription treatments.

The affordability of these products compared to prescription alternatives has also contributed to their popularity. Furthermore, marketing strategies that highlight the effectiveness of OTC cold therapy products have been widely adopted by manufacturers, thereby increasing visibility in retail settings. The regulatory landscape has supported the proliferation of these products, enabling easier access for consumers. Consequently, OTC-based products are expected to maintain a significant share of the market as consumer habits continue to evolve.

What Trends are Driving the Rapid Growth of Online Pharmacies as a Distribution Channel for Cold Pain Therapy Products?

The rapid growth of online pharmacies as a distribution channel for cold pain therapy products is being propelled by changing consumer behaviors and advancements in e-commerce. Increasing preferences for convenience and accessibility have led to a surge in online shopping for healthcare products, including cold therapy solutions. The COVID-19 pandemic has further accelerated this trend, as more consumers have turned to digital platforms for their healthcare needs to minimize exposure in physical stores.

Online pharmacies are being favored for their ability to provide a wide range of products, often at competitive prices. Enhanced delivery options and user-friendly interfaces have made the purchasing process more efficient, attracting a broader customer base. Additionally, targeted marketing and promotions have been employed by online retailers to capture consumer interest. As a result, the market share of online pharmacies is anticipated to expand significantly, reflecting a fundamental shift in how consumers access cold pain therapy products.

Country/Region-wise Acumens

What Factors are Contributing to North America's Dominance in the Cold Pain Therapy Market?

According to VMR analyst, North America's dominance in the cold pain therapy market is being attributed to several influential factors. High levels of healthcare expenditure in the region have facilitated widespread access to advanced therapeutic options, allowing patients to benefit from various cold pain therapy products. A strong emphasis on research and development by leading healthcare companies has resulted in innovative cold therapy solutions that are highly regarded in clinical settings.

Furthermore, the prevalence of chronic pain conditions and sports-related injuries in North America has created significant demand for effective pain management solutions. The influence of healthcare professionals advocating for non-invasive treatment options has further solidified the market position of cold therapy products. Consequently, North America is expected to retain a substantial share of the cold pain therapy market as consumer awareness and demand continues to grow.

How is the Rapid Growth of the Cold Pain Therapy Market Being Supported by Asia Pacific's Increasing Healthcare Expenditures?

According to VMR analyst, the rapid growth of the cold pain therapy market in the Asia Pacific is being supported by increasing healthcare expenditures and a rising population awareness regarding pain management solutions. According to the United Nations Economic and Social Commission for Asia and the Pacific (ESCAP), the number of older persons (aged 65 and above) in the Asia-Pacific region is expected to more than double from 535 million in 2015 to about 1.3 billion by 2050. Economic development in several countries within the region has led to improved healthcare infrastructure, making advanced therapy options more accessible to the general population.

The growing prevalence of chronic pain and injuries due to active lifestyles has heightened the demand for effective and convenient pain relief methods. Furthermore, government initiatives promoting health awareness and access to medical products have bolstered market growth. As consumers increasingly recognize the benefits of cold therapy for pain management, investments in healthcare technologies are being prioritized.

Competitive Landscape

The Cold Pain Therapy Market's competitive landscape is characterized by a varied range of companies, including technology developers, plant operators, and service providers, all striving for market share in an increasingly dynamic and growing industry.

Some of the prominent players operating in the cold pain therapy market include:

3M Company

Beiersdorf AG

Breg, Inc.

DJO Finance LLC

Hisamitsu Pharmaceutical Co., Inc.

Johnson & Johnson

Medline Industries, Inc.

Rohto Pharmaceutical Co., Ltd.

Latest Developments

In April 2021, Battle Creek Equipment Co. announced the launch of a line of cold therapy wraps to assist in alleviating chronic pain, acute pain, and inflammation.

In March 2019, Performance Health increased its product offering with the introduction of the Biofreeze pain treatment patch.

In 2019, Performance Health announced the launch of the Cold Patches Biofreeze Pain Relief Patch.

In 2019, DJO Global developed the cooling pads DonJoy IceMan Classic 3.

In February 2021, Breg established announced a partnership with Club Warehouse to enhance the delivery of its high-value orthopedic products in Australia. The company intends to distribute its products throughout the continent, including Australian Football League, National Rugby League, and Rugby Union Clubs.

In December 2020, Sanofi reaffirmed announced a partnership with WHO to combat some neglected diseases and eliminate sleeping sickness by 2030. Sanofi provides a specific amount of financial support for disease management, campaigns, drug donations, and so on. The cooperation is already 20 years old and helps with the screening, control, and treatment of sleeping sickness, one of the most neglected tropical diseases.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL COLD PAIN THERAPY MARKET

• 1.1 Overview of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 Data Mining
• 3.2 Validation
• 3.3 Primary Interviews
• 3.4 List of Data Sources

4 GLOBAL COLD PAIN THERAPY MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities
• 4.3 Porters Five Force Model
• 4.4 Value Chain Analysis

5 GLOBAL COLD PAIN THERAPY MARKET, BY PRODUCT

• 5.1 Overview
• 5.2 OTC Products
  • 5.2.1 Creams
  • 5.2.2 Gels
  • 5.2.3 Patches
  • 5.2.4 Others
• 5.3 Prescription Products
  • 5.3.1 Pharmaceuticals
  • 5.3.2 Medical Devices

6 GLOBAL COLD PAIN THERAPY MARKET, BY APPLICATION

• 6.1 Overview
• 6.2 Musculoskeletal Disorders
• 6.3 Post-Operative Therapy
• 6.4 Post-Trauma Therapy
• 6.5 Sports Medicine

7 GLOBAL COLD PAIN THERAPY MARKET, BY GEOGRAPHY

• 7.1 Overview
• 7.2 North America
  • 7.2.1 U.S.
  • 7.2.2 Canada
  • 7.2.3 Mexico
• 7.3 Europe
  • 7.3.1 Germany
  • 7.3.2 U.K.
  • 7.3.3 France
  • 7.3.4 Rest of Europe
• 7.4 Asia Pacific
  • 7.4.1 China
  • 7.4.2 Japan
  • 7.4.3 India
  • 7.4.4 Rest of Asia Pacific
• 7.5 Rest of the World
  • 7.5.1 Latin America
  • 7.5.2 Middle East & Africa

8 GLOBAL COLD PAIN THERAPY MARKET COMPETITIVE LANDSCAPE

• 8.1 Overview
• 8.2 Company Market Ranking
• 8.3 Key Development Strategies

9 COMPANY PROFILES

• 9.1 Breg, Inc
  • 9.1.1 Overview
  • 9.1.2 Financial Performance
  • 9.1.3 Product Outlook
  • 9.1.4 Key Developments
• 9.2 Beiersdorf AG
  • 9.2.1 Overview
  • 9.2.2 Financial Performance
  • 9.2.3 Product Outlook
  • 9.2.4 Key Developments
• 9.3 A-ssur HF
  • 9.3.1 Overview
  • 9.3.2 Financial Performance
  • 9.3.3 Product Outlook
  • 9.3.4 Key Developments
• 9.4 3M Company
  • 9.4.1 Overview
  • 9.4.2 Financial Performance
  • 9.4.3 Product Outlook
  • 9.4.4 Key Developments
• 9.5 DJO Finance LLC
  • 9.5.1 Overview
  • 9.5.2 Financial Performance
  • 9.5.3 Product Outlook
  • 9.5.4 Key Developments
• 9.6 Hisamitsu Pharmaceutical Co., Inc
  • 9.6.1 Overview
  • 9.6.2 Financial Performance
  • 9.6.3 Product Outlook
  • 9.6.4 Key Developments
• 9.7 Johnson & Johnson
  • 9.7.1 Overview
  • 9.7.2 Financial Performance
  • 9.7.3 Product Outlook
  • 9.7.4 Key Developments
• 9.8 Medline Industries, Inc
  • 9.8.1 Overview
  • 9.8.2 Financial Performance
  • 9.8.3 Product Outlook
  • 9.8.4 Key Developments
• 9.9 Rohto Pharmaceutical Co., Ltd
  • 9.9.1 Overview
  • 9.9.2 Financial Performance
  • 9.9.3 Product Outlook
  • 9.9.4 Key Developments
• 9.10 Sanofi
  • 9.10.1 Overview
  • 9.10.2 Financial Performance
  • 9.10.3 Product Outlook
  • 9.10.4 Key Developments

10 Appendix

• 10.1 Related Research